Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
27%
OVERLAP
BY WEIGHT
8
# OF OVERLAPPING
HOLDINGS
IXJ
114
HOLDINGS
8%
ALSO IN THNR
THNR
19
HOLDINGS
42%
ALSO IN IXJ
SECTOR DRIFT (IXJ minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IXJ |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 9.7% | 8.4% | 8.4% |
|
ABBVIE INC | 4.9% | 5.0% | 4.9% |
|
MERCK & CO. INC. | 4.5% | 5.5% | 4.5% |
 |
ASTRAZENECA PLC | 3.0% | 4.0% | 3.0% |
|
AMGEN INC | 2.8% | 5.6% | 2.8% |
IXJ Overweight Relative to THNR
|
JOHNSON & JOHNSON | 7.1% |
|
UNITEDHEALTH GROUP INC | 3.9% |
 |
NOVARTIS AG | 3.5% |
|
THERMO FISHER SCIENTIFIC INC | 2.8% |
|
ABBOTT LABORATORIES | 2.3% |
|
GILEAD SCIENCES INC | 2.3% |
 |
NOVO NORDISK A/S-B | 1.8% |
|
VERTEX PHARMACEUTICALS INC | 1.7% |
|
BRISTOL-MYERS SQUIBB CO | 1.6% |
|
DANAHER CORP | 1.6% |
IXJ Underweight Relative to THNR
|
NOVO-NORDISK A/S-SPONS ADR | -9.0% |
 |
INNOVENT BIOLOGICS, INC. | -6.1% |
 |
CHINA PHARMACEUTICAL GROUP | -5.9% |
|
SCHOLAR ROCK HOLDING CORP. | -5.4% |
|
REGENERON PHARMACEUTICALS | -5.1% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -5.1% |
|
VIKING THERAPEUTICS, INC. | -4.7% |
|
HIMS & HERS HEALTH, INC. CLASS A | -4.2% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -3.7% |
|
ZEALAND PHARMA A/S | -3.5% |